ruthenium has been researched along with plumbagin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bharathi, A; Polasa, H | 1 |
| Biersack, B; Mahal, K; Schobert, R; Spoerlein-Guettler, C | 1 |
| Chen, NF; Chen, ST; Chen, ZF; Li, YL; Liang, H; Yang, Y; Zhu, XM | 1 |
3 other study(ies) available for ruthenium and plumbagin
| Article | Year |
|---|---|
Elimination of broad-host range plasmid vectors in Escherichia coli by curing agents.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cisplatin; Coumarins; Escherichia coli; Genetic Vectors; Naphthoquinones; Plasmids; Ruthenium; Ruthenium Compounds; Santonin; Sodium Dodecyl Sulfate | 1991 |
Ferrocene and (arene)ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Coordination Complexes; Cymenes; DNA; Female; Ferrous Compounds; Humans; Metallocenes; Monoterpenes; Naphthoquinones; Ruthenium; Uterine Cervical Neoplasms | 2014 |
Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Coordination Complexes; Energy Metabolism; Humans; Ligands; Mice; Mice, Nude; Naphthoquinones; Ruthenium | 2022 |